---
name: BioInnovatise
slug: bioinnovatise
site: cdmo
website_domain: bioinnovatise.com
summary: BioInnovatise provides fast, reliable CDMO services for plasmid DNA, viral vector packaging, and CRISPR-Cas9 research with turnaround times of 7–28 days.
tagline: Fast, reliable CDMO services for plasmid DNA and viral vector research.
founded_year: 
employee_count_band: 
employee_count_label: 
parent_name: 
parent_slug: 
hq_country: 
tier2_domain_verified: false
updated_at: 2026-09-19T07:00:51.386Z
services_count: 6
modalities_count: 3
indications_count: 0
locations_count: 0
review_signal_gate: closed
generated_by: BioBM Editorial AI
---

# BioInnovatise

Fast, reliable CDMO services for plasmid DNA and viral vector research.

Listed on cdmo.directory.

## Summary

BioInnovatise provides fast, reliable CDMO services for plasmid DNA, viral vector packaging, and CRISPR-Cas9 research with turnaround times of 7–28 days.

## Services

- Cell-Line Development
- Viral Vector Manufacturing
- AAV Manufacturing
- Lentiviral Vector Manufacturing
- Translational Research
- Discovery Research

## Modalities

- AAV / Viral Vector Platform
- Gene Therapy
- Cell Therapy

## Long description

BioInnovatise accelerates scientific discovery by offering high-quality CDMO services for plasmid DNA and viral vector-based research. The company collaborates with researchers in government, academia, and industry to support innovation in cell and gene therapy, immunotherapy, and precision medicine.

**Core Service Offerings:**

- **Plasmid DNA Services:** Molecular cloning (14 days), mutagenesis (Kunkel, PCR site-directed, random, saturation, transposon; 7–14 days), plasmid preparation (midiprep 7 days, maxiprep 14 days, large-scale up to 1 gram), and plasmid library construction (21–28 days).
- **Viral Vector Packaging:** AAV, adenovirus, lentivirus, and retrovirus packaging at small (500 μl, 14–28 days) and large (1 ml, 14–28 days) scales.
- **CRISPR-Cas9 Services:** CRISPR vectors (14 days), sgRNA cloning (7–14 days), cassette production and donor vector construction (14 days), and CRISPR knock-in/knock-out (4 months).
- **Primary Mouse Embryonic Fibroblasts:** Available with 3-week turnaround.

The company emphasizes rapid turnaround times and serves researchers across multiple therapeutic areas and disciplines.

## Related companies

- [Genezen](/companies/genezen) (Cell-Line Development, Viral Vector Manufacturing) — [Compare](/compare/bioinnovatise/genezen)
- [VVector Bio](/companies/vvectorbio) (Translational Research, AAV / Viral Vector Platform) — [Compare](/compare/bioinnovatise/vvectorbio)
- [Andelyn Biosciences](/companies/andelynbio) (Cell-Line Development, Viral Vector Manufacturing) — [Compare](/compare/andelynbio/bioinnovatise)
- [Cell and Gene Therapy Catapult](/companies/ct) (Cell-Line Development, Viral Vector Manufacturing) — [Compare](/compare/bioinnovatise/ct)
- [Porton Advanced](/companies/porton-advanced) (Cell-Line Development, Viral Vector Manufacturing) — [Compare](/compare/bioinnovatise/porton-advanced)
- [Creative Biogene](/companies/creative-biogene) (Cell-Line Development, Viral Vector Manufacturing) — [Compare](/compare/bioinnovatise/creative-biogene)
- [Aldevron](/companies/aldevron) (Cell-Line Development, Viral Vector Manufacturing) — [Compare](/compare/aldevron/bioinnovatise)
- [Minaris Advanced Therapies](/companies/wuxi-advanced-therapies) (Cell-Line Development, Viral Vector Manufacturing) — [Compare](/compare/bioinnovatise/wuxi-advanced-therapies)

_Profile last updated: 2026-09-19T07:00:51.386Z. Profile facts may include AI-assisted enrichment._

Auto-generated by BioBM Editorial AI for machine-readable profile access.